The additional possibilities to increase the efficacy in the treatment of different types of headaches

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Medvedeva L.A.

FGBU "RNTsKh im. akad. B.V. Petrovskogo" RAMN

Avakian G.N.

Department of Neurology and Neurosurgery of the N.I. Pirogov Russian National Research Medical University

SPIN RSCI: 1355-5130
Scopus AuthorID: 6701409996

Zagorulko O.I.

Petrovsky Russian Research Center of Surgery

ORCID: 0000-0002-2713-9577

Gnezdilov A.V.

Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo RAMN, Moskva

The additional possibilities to increase the efficacy in the treatment of different types of headaches

Authors:

Medvedeva L.A., Avakian G.N., Zagorulko O.I., Gnezdilov A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5): 87‑89

Views: 437

Downloaded: 5

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Medvedeva LA, Avakian GN, Zagorulko OI, Gnezdilov AV. The additional possibilities to increase the efficacy in the treatment of different types of headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5):87‑89. (In Russ.)

Close metadata

Keywords:

primary headaches

seconary headaches

mexidol

complex pathogenetic therapy

Authors:

Medvedeva L.A.

FGBU "RNTsKh im. akad. B.V. Petrovskogo" RAMN

Avakian G.N.

Department of Neurology and Neurosurgery of the N.I. Pirogov Russian National Research Medical University

SPIN RSCI: 1355-5130
Scopus AuthorID: 6701409996

Zagorulko O.I.

Petrovsky Russian Research Center of Surgery

ORCID: 0000-0002-2713-9577

Gnezdilov A.V.

Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo RAMN, Moskva

List of references:

Amelin A.V., Ignatov Yu.D., Skoromets A.A. Migren'. Patogenez, klinika i lechenie. St-Peterburg 2001;200.
Val'dman A.V., Voronina T.A., Smirnov L.D. i dr. Vliyanie proizvodnykh 3-oksipiridina na tsentral'nuyu nervnuyu sistemu. Byull eksper biol i med 1985;99:1:60-62.
Voronina T.A., Nerobkova L.N., Markina N.V. i dr. Vozmozhnye mekhanizmy deistviya membranoaktivnykh veshchestv s antioksidantnymi svoistvami v ekstremal'nykh situatsiyakh. V kn.: Kletochnye mekhanizmy realizatsii farmakologichekogo effekta. Pod red. S.B. Seredenina. M 1990;54-77.
Voronina T.A. Antioksidant meksidol. Osnovnye effekty i mekhanizm deistviya. Psikhofarmakol i biol (narkologiya) 2001;1:2-12.
Goidenko V.S., Kozlov A.V. Golovnaya bol' (patofiziologiya i refleksoterapiya). Uchebnoe posobie. M 2002;96.
Ivashkin V.T., Shul'pekova Yu.O. Nervnye mekhanizmy bolevoi chuvstvitel'nosti. Ros zhurn gastroenterol gepatol koloproktol 2002; 12:4:16-20.
Kutsemelov I.B., Tabeeva G.R. Epidemiologiya pervichnoi golovnoi boli (po dannym populyatsionnogo issledovaniya vzroslogo naseleniya Rostova-na-Donu). Bol' 2004;4:5:25-31.
Medvedeva L.A., Gnezdilov A.V., Zagorul'ko O.I. i dr. Effektivnost' neiroprotektorov v snizhenii golovnykh bolei napryazheniya. Zhurn nevrol i psikhiat 2006;106:5:38-41.
Medvedeva L.A., Dutikova E.F., Shcherbakova N.E. i dr. Kompleksnaya patogeneticheskaya terapiya golovnykh bolei, obuslovlennykh degenerativno-distroficheskimi izmeneniyami sheinogo otdela pozvonochnika s yavleniyami venoznogo zastoya. Zhurn nevrol i psikhiat 2007;107: 11:36-40.
Medvedeva L.A., Zagorul'ko O.I., Gnezdilov A.V. Integrativnyi podkhod k diagnostike i lecheniyu migreni. Zhurn nevrol i psikhiatr (prilozhenie «Prakticheskaya nevrologiya») 2007;107:2:36-40.
Voronina T.A., Smirnov L.D., Teleshova E.S. i dr. Antistressornye effekty antioksidanta meksidola i ego analogov v ekstremal'nykh situatsiyakh. Tavricheskii zhurn psikhiat 2002;6:2:73-74.
Tabeeva G.R., Vein A.M. Khronicheskaya ezhednevnaya golovnaya bol'. Consilium Medicum 1999;1:2:66-72.
Yanishevskii S.N. Opyt primeneniya preparata meksidol v lechenii khronicheskoi nedostatochnosti mozgovogo krovoobrashcheniya u patsientov so stenoziruyushche-okklyuziruyushchim porazheniem magistral'nykh brakhitsefal'nykh sosudov. Byull eksper biol i med (prilozhenie 1) 2006;159-163.
Bigal M.E., Rapoport A.M., Hargreaves R. Advances in the pharmacologic treatment of tension-type headache. Curr Pain Headache Rep 2008;12: 6:442-446.
Brandes J.L., Saper J.R., Diamond M. et al. Topiramate for migraine prevention. A randomized controlled trial. JAMA 2004;291:8:965-973.
Deyo R.A., Weinstein J.N. N Engl J Med 2001;344:5:363-370.
Dodick D.W. Chronic daily headache. N Engl J Med 2006;354:8:884.
Epidemiology of Pain: A Report of the Task Force on Epidemiology of the International Association for the Study of Pain and members of the Task Force on Epidemiology Eds. I.K. Crombie et al. Seattle: IASP Press 1999.
Gerwin R.D. Classification, Epidemiology, and Natural History of Myofascial Pain Syndrome. Curr Pain Headache Rep 2001;5:412-420.
Harden R.N., Bruehl S.P., Gass S. et al. A national survey of Pain management providers. Clin J Pain 2000;16:64-72.
Jensen R., Rasmussen B. K., Olesen J. Muscle tenderness and pressure pain thresholds in headache: a population study. Pain 1993;52:193-199.
Lipton R.B., Stewart W.F. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993;48:Suppl 3:S6-S10.
Rasmussen B.K. Migraine and tension-type headache in a general population: psychosocial factors. Int J Epidemiol 1992; 21:1138-1143.
The International classification of headache disorder 2nd edition. Cephalalgia 2004;24:Suppl 1.
Wheeler A.H. Myofascial pain disorders: theory to therapy. Drugs 2004;64:1:45-62.

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.